Glaucoma Now is a continuing medical education publication. Based on the information found in each issue, an associated e-learning course is offered.
Distributed worldwide, the goal of Glaucoma Now is to educate and update general ophthalmologists, glaucoma specialists and ophthalmology residents. International leaders in the field of glaucoma are invited to contribute to this journal, sharing their most recent insights.
Supported by an unrestricted educational grant from Allergan Inc., the publication is non-promotional and has a fully independent Editorial Board. Supporting companies are: Allergan plc, Mundipharma Australia, Novartis Pharmaceuticals Australia Pty Ltd, and Pfizer Inc.
Individual issues of Glaucoma Now are accredited for Continuing Medical Education (CME) by the Physicians' Chamber of Baden-Württemberg, Germany (Local Medical Responsible: Andreas Buchholz, MD, PhD, ROph). This accreditation automatically implies acceptance of credits throughout the European Union and associated countries.
Glaucoma Now is also recognised by the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) as a valid Continuing Professional Development activity.
Since 2013 the program is recognized by the Brazilian Council of Ophthalmology. Brazilian physicians successfully taking CME tests on our website are automatically awarded CME points by CBO.